Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,679 | Dovepress* | 5,258+ | 678 | 5,936 | |
| PubMed Central* | 421 | 128 | 549 | ||
| Totals | 5,679 | 806 | 6,485 | ||
|
*Since 11 May 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar